AI-powered kids' toys like Miko 3 have hit shelves this holiday season, claiming to rely on sophisticated chatbots to animate interactive robots for children.

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP). Launched in December 2024, with the inaugural cohort ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

"The Founders chose this name to signal our strength and resolve to the world," the order declared. "The name 'Department of ...

Over the last decade, the number of cell and gene therapy clinical trials has more than tripled. In this article, several ...

"My biggest advice is to find great partners to build with. Starting a firm is incredibly challenging and requires a ...

Swine acute diarrhoea syndrome coronavirus has the potential to spill over to humans and animals, researchers say.

To address this, Thermo Fisher Scientific now offers Accelerator Drug Development: a suite of integrated services combining CDMO and CRO capabilities to streamline the drug development journey, from ...

India’s deep-tech journey needs smarter funding, stronger R&D and industry–academia collaboration. FSID’s Yogesh Pandit explains the gaps and the path to 2047 ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

HPE’s product roadmap is centered on networking, cloud and AI, and that focus is reflected in the work of HPE Labs. "All of ...

Today, The Jackson Laboratory (JAX) announced a bold initiative to improve that trajectory, powered by an up to $30 million contract from the Advanced Research Projects Agency for Health (ARPA-H) ...